PortfoliosLab logoPortfoliosLab logo
TMED vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

TMED vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Health Care ETF (TMED) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TMED achieves a 2.81% return, which is significantly higher than XLVI's -1.33% return.


TMED

1D
-2.33%
1M
1.95%
YTD
2.81%
6M
4.16%
1Y
3Y*
5Y*
10Y*

XLVI

1D
-0.73%
1M
1.42%
YTD
-1.33%
6M
0.46%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TMED vs. XLVI - Yearly Performance Comparison


Correlation

The correlation between TMED and XLVI is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 31, 2025

0.85

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TMED vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

TMED vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


TMEDXLVIDifference

Sharpe Ratio (All Time)

Calculated using the full available price history

1.29

1.25

+0.04

Drawdowns

TMED vs. XLVI - Drawdown Comparison

The maximum TMED drawdown since its inception was -11.11%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for TMED and XLVI.


Loading charts...

Drawdown Indicators


TMEDXLVIDifference

Max Drawdown

Largest peak-to-trough decline

-11.11%

-8.14%

-2.97%

Current Drawdown

Current decline from peak

-3.75%

-4.66%

+0.91%

Average Drawdown

Average peak-to-trough decline

-2.59%

-1.94%

-0.65%

Volatility

TMED vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


TMEDXLVIDifference

Volatility (1Y)

Calculated over the trailing 1-year period

18.05%

10.94%

+7.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.05%

10.94%

+7.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.05%

10.94%

+7.11%

TMED vs. XLVI - Expense Ratio Comparison

TMED has a 0.44% expense ratio, which is higher than XLVI's 0.35% expense ratio.


Dividends

TMED vs. XLVI - Dividend Comparison

TMED's dividend yield for the trailing twelve months is around 0.53%, less than XLVI's 11.61% yield.


Frequently Asked Questions


TMED and XLVI have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XLVI is cheaper with a 0.35% expense ratio, compared with 0.44% for TMED.

XLVI has the higher dividend yield at 11.61%, compared with 0.53% for TMED.

TMED is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: T. Rowe Price and State Street. Their fees differ too: 0.44% for TMED and 0.35% for XLVI.

Portfolio Optimizer

Find the right allocation for TMED and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer